GenoPalate, Inc., a Milwaukee-based early-stage nutritional genomics company, has completed a $4 million round of equity financing from local investors.  This is the third round of funding for the company. The funds will be used to expand the capacity of GenoPalate’s internet platform so the company can engage 3,000 or more new customers a day for their personal nutrition needs, which will more than double its current capacity.

GenoPalate, Inc. empowers customers to eat better and healthier through science and personalization. GenoPalate's simple home nutrition DNA test analyzes 100+ genetic markers that determine a person's specific needs for vital nutrients such as carbohydrates, vitamin D, and sodium. That combined with millions of nutritional variables produces a personalized report recommending foods that will provide the most benefit for a person’s health.

Biotech Company GenoPalate Closes $4 Million Series A Financing-Investment In Personalized Healthy Eating Continues To Grow

Biotech Company GenoPalate Closes $4 Million Series A Financing-Investment In Personalized Healthy Eating Continues To Grow

Company Info